Allen v. Boehringer Ingelheim Pharmaceuticals, Inc. et al
Consolidated
Lead case: 9:20-md-02924
Lead case: 9:20-md-02924
Florida Southern District Court | |
Judge: | Robin L Rosenberg |
Case #: | 9:20-cv-80461 |
Nature of Suit | 367 Torts - Personal Injury - Health Care/Pharmaceutical Personal Injury/Product Liability |
Cause | 28:1332 Diversity-Product Liability |
Case Filed: | Mar 20, 2020 |
Terminated: | Mar 23, 2020 |
Case in other court: | Tennessee Western, 2:20-cv-02141 |
Last checked: Wednesday Sep 16, 2020 6:18 AM EDT |
Defendant
Boehringer Ingelheim Pharmaceuticals, Inc.
|
|
Defendant
GlaxoSmithKline LLC
|
|
Defendant
Inc Pfizer
|
|
Defendant
Sanofi US Services, Inc.
1201 Hays Street
Tallahassee, FL 32301 |
|
Plaintiff
Curtis Allen
6125 Talon Drive Apt. 151E
Memphis, TN 38115 |
Represented By
|
Docket last updated: 11 hours ago |
Tuesday, June 28, 2022 | ||
19 | 19
order
- Order (PAPERLESS or pdf attached) ~Util - Terminate Case Associations
Wed 06/29 7:50 AM
ORDER Deconsolidating Cases. This case is DECONSOLIDATED from MDL proceeding 20-MD-2924. Case remains closed. Signed by Judge Robin L. Rosenberg on 6/27/2022. See attached document for full details. (pes) |
|
Wednesday, June 22, 2022 | ||
18 | 18
notice
Notice of Voluntary Dismissal - aty
Wed 06/22 9:48 AM
NOTICE of Voluntary Dismissal without Prejudice by Curtis Allen (Dellaccio, Douglas) |
|
Tuesday, November 09, 2021 | ||
17 | 17
cmp
Amended Complaint/Amended Notice of Removal
Tue 11/09 1:13 PM
Third AMENDED COMPLAINT against Boehringer Ingelheim Pharmaceuticals, Inc., GlaxoSmithKline LLC, filed by Curtis Allen.(Dellaccio, Douglas) |
|
Tuesday, November 02, 2021 | ||
16 | 16
notice
Notice of Attorney Appearance
Tue 11/02 2:02 PM
NOTICE of Attorney Appearance by Jon C. Conlin on behalf of Curtis Allen. Attorney Jon C. Conlin added to party Curtis Allen(pty:pla). (Conlin, Jon) |
|
Tuesday, October 26, 2021 | ||
14 | 14
motion
Withdraw as Attorney
Tue 10/26 4:37 PM
MOTION to Withdraw as Attorney by Curtis Allen. Attorney Douglas A. Dellaccio, Jr added to party Curtis Allen(pty:pla). Responses due by 11/9/2021 (Dellaccio, Douglas) |
|
order
Order on Motion to Withdraw as Attorney
Tue 10/26 5:15 PM
PAPERLESS ORDER granting14 Motion to Withdraw as Attorney. Lauren S. Miller representing Allen, Curtis (Plaintiff) is withdrawn from this case. Signed by Judge Robin L. Rosenberg on 10/26/2021. (sk01) |
||
Thursday, June 24, 2021 | ||
13 | 13
cmp
Amended Complaint/Amended Notice of Removal
Thu 06/24 5:36 PM
Second AMENDED COMPLAINT Short-Form (Version 2) against Boehringer Ingelheim Pharmaceuticals, Inc., GlaxoSmithKline LLC, Sanofi US Services, Inc., filed by Curtis Allen.(Miller, Lauren) |
|
Friday, August 21, 2020 | ||
12 | 12
cmp
Amended Complaint/Amended Notice of Removal
Fri 08/21 6:25 PM
AMENDED COMPLAINT Short-Form Complaint against Boehringer Ingelheim Pharmaceuticals, Inc., GlaxoSmithKline LLC, Inc Pfizer, Sanofi US Services, Inc., filed by Curtis Allen.(Miller, Lauren) |
|
Monday, March 23, 2020 | ||
11 | 11
order
Administrative Order
Mon 03/23 12:48 PM
ORDER OF CONSOLIDATION AND ADMINISTRATIVE CLOSE-OUT. Signed by Judge Robin L. Rosenberg on 3/23/2020. See attached document for full details. (mc) |
|
Friday, March 20, 2020 | ||
10 | 10
transfer
MDL Tag-Along/Transfer In Case Receipt
Fri 03/20 4:13 PM
MDL Transfer In Case Receipt from Western District of Tennessee. Case Number 2:20-cv-02141 with documents 1-7. Assigned FLSD Case Number 9:20-cv-80461-RLR on 3/20/2020. Re: FLSD MDL Case Number 9:20-md-02924-RLR. (mc) |
|
9 | 9
order
Clerk's Notice of Judge Assignment and Optional Consent
Fri 03/20 4:09 PM
Clerks Notice of Judge Assignment to Judge Robin L. Rosenberg. (mc) |
|
8 | 8
transfer
Case Transferred In - District Transfer - CV - NO FEE
Fri 03/20 4:07 PM
Case transferred in from Tennessee Western; Case Number 2:20-cv-02141. Electronic file including transfer order and docket sheet received. .(mc). |
|
Wednesday, March 18, 2020 | ||
7 | 7 CONDITIONAL TRANSFER ORDER (CTO-5) MDL No. 2924. Signed by John W. Nichols, Clerk of Panel on 3/18/2020.(agj) | |
Att: 1 Transmittal Notice | ||
Friday, February 28, 2020 | ||
6 | 6 Summons Issued as to Boehringer Ingelheim Pharmaceuticals, Inc., GlaxoSmithKline, LLC, Pfizer, Inc., Sanofi US Services, Inc.. The filer has been notified electronically that the summons has been issued, and the new docket entry reflects this. Upon notification of the new docket entry, the filer is to print the issued summons in order to effect service.(jae) | |
Att: 1 summons - Glaxo Smith, | ||
Att: 2 Pfizer, | ||
Att: 3 Sanofi | ||
5 | 5 NOTICE OF RIGHT TO CONSENT TO THE EXERCISE OF CIVIL JURISDICTION BY A MAGISTRATE JUDGE Pursuant to 28 U.S.C. 636(c), Fed.R.Civ.P.73, and Local Rule 72.1, this Court has designated the Magistrate Judges of this District to conduct trials and otherwise dispose of any civil case that is filed in this Court. Your decision to consent, or not consent, to the referral of your case to a United States Magistrate Judge for trial and entry of a final judgment must be entirely voluntary. The judge or magistrate judge to whom the case has been assigned will not be informed of your decision unless all parties agree that the case may be referred to a magistrate judge for these specific purposes. A less than unanimous decision will not be communicated by this office to either the judge or magistrate judge. The consent form is available on the courts website at https://www.tnwd.uscourts.gov/forms-and-applications.php (jae) | |
4 | 4 NOTICE TO COMPLY WITH PLAN FOR ALTERNATE DISPUTE RESOLUTION (ADR): Pursuant to Section to 2.1 of the ADR Plan, all civil cases filed on or after Sept. 1, 2014, shall be referred automatically for ADR. For compliance requirements, refer to the ADR Plan at: http://www.tnwd.uscourts.gov/pdf/content/ADRPlan.pdf (jae) | |
3 | 3 NOTICE OF CASE TRACKING ASSIGNMENT PURSUANT TO LOCAL RULE 16.2: Pursuant to Local Rule 16.2, this case has been assigned to the Standard track. http://www.tnwd.uscourts.gov/pdf/content/LocalRules.pdf (jae) | |
2 | 2 Judge Sheryl H. Lipman and Magistrate Judge Charmiane G. Claxton added. (jae) | |
1 | 1 COMPLAINT against Boehringer Ingelheim Pharmaceuticals, Inc., GlaxoSmithKline, LLC, Pfizer, Inc., Sanofi US Services, Inc. (Filing fee $ 400 receipt number ATNWDC-3297284), filed by Curtis Allen.(Herring, Andrew) | |
Att: 1 Civil Cover Sheet, | ||
Att: 2 Summons Boehringer Ingelheim Pharmaceuticals, Inc., | ||
Att: 3 Summons Sanofi US Services, Inc., | ||
Att: 4 Summons Pfizer, Inc., | ||
Att: 5 Summons GlaxoSmithKline, LLC |